Bob Scribner

Bob Scribner has a diverse work experience, with a focus on the medical and technology fields. Bob has held various leadership positions and advisory roles in multiple companies. In 1994, they served as a Director at Encore Medical/Vanguard Medical Concepts Inc. Bob then worked at Kyphon, Inc. from 1996 to 2001, holding positions as VP and Director of R&D. In 2001, they became the CTO, President, and Founder of Archus Orthopedics, Inc. Following this, they advised InBone Technologies, Inc. and Bonovo Orthopedics, Inc. on initial capitalization and financing. From 2004 to 2017, they were the CEO and Director at Crosstrees Medical, Inc., specializing in spine surgery technology. During this time, they also served as an advisor to Click Nucleic Acids, Inc., a company focused on nucleic acid synthesis. In 2017, they became the COO of Diaxamed, LLC. Bob Scribner also served as a Board Member at Respirogen and Truly Oxygen Inc., starting in 2017 and 2019 respectively.

Bob Scribner has a Bachelor of Science (BS) degree in Mechanical Engineering from Northeastern University. Additionally, they hold an Executive MBA from the University of Denver - Daniels College of Business. Bob has also obtained a certification in Drug and Medical Device Development: A Strategic Approach from Emeritus - MIT in July 2020.